DEBRISOQUINE HYDROXYLATION PHENOTYPE, ACETYLATION PHENOTYPE, AND ABO BLOOD-GROUPS AS GENETIC HOST FACTORS OF LUNG-CANCER RISK

被引：0
|
作者：
ROOTS, I [1 ]
DRAKOULIS, N [1 ]
PLOCH, M [1 ]
HEINEMEYER, G [1 ]
LODDENKEMPER, R [1 ]
MINKS, T [1 ]
NITZ, M [1 ]
OTTE, F [1 ]
KOCH, M [1 ]
机构：
[1] LUNGENKLIN HECKESHORN,BERLIN,FED REP GER
来源：
KLINISCHE WOCHENSCHRIFT | 1988年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：87 / 97
页数：11
相关论文
共 36 条
  • [1] LUNG-CANCER AND THE DEBRISOQUINE METABOLIC PHENOTYPE
    CAPORASO, NE
    TUCKER, MA
    HOOVER, RN
    HAYES, RB
    PICKLE, LW
    ISSAQ, HJ
    MUSCHIK, GM
    GREENGALLO, L
    BUIVYS, D
    AISNER, S
    RESAU, JH
    TRUMP, BF
    TOLLERUD, D
    WESTON, A
    HARRIS, CC
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (15) : 1264 - 1272
  • [2] LUNG-CANCER RISK, OCCUPATIONAL EXPOSURE, AND THE DEBRISOQUINE METABOLIC PHENOTYPE
    CAPORASO, N
    HAYES, RB
    DOSEMECI, M
    HOOVER, R
    AYESH, R
    HETZEL, M
    IDLE, J
    CANCER RESEARCH, 1989, 49 (13) : 3675 - 3679
  • [3] DEBRISOQUINE OXIDATION PHENOTYPE AND SUSCEPTIBILITY TO LUNG-CANCER
    BOOBIS, AR
    DAVIES, DS
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (04) : 653 - 656
  • [4] DEBRISOQUINE OXIDATION PHENOTYPE AND SUSCEPTIBILITY TO LUNG-CANCER
    SPEIRS, CJ
    MURRAY, S
    DAVIES, DS
    MABADEJE, AFB
    BOOBIS, AR
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (01) : 101 - 109
  • [5] BLOOD-GROUPS AND LUNG-CANCER
    ROBERTS, TE
    HASLETON, P
    SWINDELL, R
    LAWSON, R
    BRITISH JOURNAL OF CANCER, 1988, 58 (02) : 278 - 278
  • [6] IS THERE A LINK BETWEEN DEBRISOQUINE OXIDATION PHENOTYPE AND LUNG-CANCER SUSCEPTIBILITY
    HORSMANS, Y
    DESAGER, JP
    HARVENGT, C
    BIOMEDICINE & PHARMACOTHERAPY, 1991, 45 (08) : 359 - 362
  • [7] THE DEBRISOQUINE METABOLIC PHENOTYPE AND DNA-BASED ASSAYS - IMPLICATIONS OF MISCLASSIFICATION FOR THE ASSOCIATION OF LUNG-CANCER AND THE DEBRISOQUINE METABOLIC PHENOTYPE
    CAPORASO, NE
    SHIELDS, PG
    LANDI, MT
    SHAW, GL
    TUCKER, MA
    HOOVER, R
    SUGIMURA, H
    WESTON, A
    HARRIS, CC
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1992, 98 : 101 - 105
  • [8] GENETIC HOST FACTORS POSSIBLY PREDISPOSING TO GASTRIC-CANCER - HYDROXILATOR AND ACETYLATOR STATUS AND ABO BLOOD-GROUPS
    ROOTS, I
    SCHUTZE, S
    KORGE, M
    DRAKOULIS, N
    HEINEMEYER, G
    KAMPF, D
    LOCH, H
    KARAVIAS, T
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 220 - 220
  • [9] Interethnic differences in drug metabolism: Influence of genetic and environmental factors on debrisoquine hydroxylation phenotype
    Llerena, A
    Cobaleda, J
    Martinez, C
    Benitez, J
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1996, 21 (02) : 129 - 138
  • [10] BLOOD-GROUPS IN LUNG-CANCER PATIENTS AND THE EFFECTS OF IMMUNOTHERAPY
    ANTHONY, HM
    BRITISH JOURNAL OF CANCER, 1982, 46 (03) : 513 - 513
1234